Shikha Jain, Shea Holman: It’s time for NIH to be transparent about how misconduct cases are handled

Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting

NIH Director Monica M. Bertagnolli delivered the Charles G. Moertel Lecture at the Fall Group Meeting of the Alliance for Clinical Trials in Oncology. The meeting took place Oct. 30-Nov. 1.

November 15, 2024

Vol.50 No.43

In Brief

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from NIH to improve follow-up care for colorectal cancer screening in underserved populations.

October 04, 2024

Vol.50 No.37

PubMed’s failure to display all papers by authors who publish under multiple names “mistreats women,” lawsuit contends

A law group associated with conservative causes and funded by leading conservative donors has sued NIH, HHS, and the National Library of Medicine, demanding that the institutions address PubMed’s inability to display all papers authored by researchers who have published under multiple names.

Roger Lo awarded $2M NIH grant to study melanoma treatment resistance

Roger Lo, professor of medicine, dermatology, and molecular and medical pharmacology and investigator at the UCLA Health Jonsson Comprehensive Cancer Center, was awarded a $2 million grant from NIH to investigate innovative strategies to prevent drug resistance in melanoma treatment and improve the effectiveness of MAPK inhibitors, a common treatment for patients with melanomas that carry the BRAFV600 mutation.

September 27, 2024

Vol.50 No.36

In Brief

UF receives $3.5M NIH grant to train pain researchers

To address the need for nonaddictive methods to treat pain, a University of Florida team has been awarded a $3.5 million grant from NIH to train postdoctoral fellows seeking to become independent clinical pain researchers.

September 20, 2024

Vol.50 No.35

Clinical Roundup

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

West African genetic ancestry was associated with increased prostate cancer among men living in disadvantaged neighborhoods but not among men living in more affluent neighborhoods, according to a new study led by NIH researchers. The findings suggest that neighborhood environment may play a role in determining how genetic ancestry influences prostate cancer risk.

September 20, 2024

Vol.50 No.35

Shikha Jain, Shea Holman: It’s time for NIH to be transparent about how misconduct cases are handled

YOU MAY BE INTERESTED IN

Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

PubMed’s failure to display all papers by authors who publish under multiple names “mistreats women,” lawsuit contends

Roger Lo awarded $2M NIH grant to study melanoma treatment resistance

UF receives $3.5M NIH grant to train pain researchers

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

Renew today!

Subscriber content

Never miss an issue!

Login